Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elisa Gallerani
Institution:
Aziende Socio Sanitarie Territoriale dei Sette Laghi
Observed institution:
Aziende Socio Sanitarie Territoriale dei Sette Laghi
ORCID:
0000-0001-9394-8535
Observed ORCID:
0000-0001-9394-8535
OpenAlex ID:
A5019580971
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025
·
Harriet Johansson
, Debora Macis
, et al.
·
Clinical Cancer Research
·
6
PDF
Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase 3 trial in noninvasive breast cancer
2025
·
Alessio Carbone
, Martino Oliva
, et al.
·
JNCI Journal of the National Cancer Institute
·
2
Abstract P3-12-07: SARELIFE study: Safety and efficacy of Sacituzumab Govitecan (SG) in pretreated metastatic triple negative breast cancer (mTNBC): a multicentric, real-life study
2025
·
Elena Florio
, Giovanna Catania
, et al.
·
Clinical Cancer Research
·
1
Supplementary Table S3 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025
·
Harriet Johansson
, Debora Macis
, et al.
Supplementary Figure S2 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025
·
Harriet Johansson
, Debora Macis
, et al.
PDF
Supplementary Table S2 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025
·
Harriet Johansson
, Debora Macis
, et al.
Supplementary Figure S4 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025
·
Harriet Johansson
, Debora Macis
, et al.
PDF
Supplementary Figure S1 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025
·
Harriet Johansson
, Debora Macis
, et al.
Supplementary Figure S3 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025
·
Harriet Johansson
, Debora Macis
, et al.
Supplementary Figure S5 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025
·
Harriet Johansson
, Debora Macis
, et al.
Supplementary Table S4 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025
·
Harriet Johansson
, Debora Macis
, et al.
Data from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025
·
Harriet Johansson
, Debora Macis
, et al.
Supplementary Table S1 from Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
2025
·
Harriet Johansson
, Debora Macis
, et al.
Show more works
View as search
Works count:
13
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type